Perhaps it's time for America's drug company executives to schedule a long conference call with America's tobacco company executives to have a little chat about liability.
Big Pharma's efforts to somehow put a lid on the brewing opioid controversy received a major blow in what was once a pharmaceuticals stronghold: Texas. Several (mostly rural) counties around the Lone Star state have already sued drug makers for not taking proper steps to limit the distribution of opioids within their jurisdictions. But now the topic has heated up.
What's causing the opioid uproar in Texas is an alignment of supposedly disparate actions. The state attorney general, finally reacting to increasing opioid-related deaths and suits by several counties, jumped in on a national investigation of opioid drug manufacturers.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
